- Home
- BCAL vs PSNL Comparison
BCAL vs PSNL Comparison
Compare BCAL & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCAL
- PSNL
- Stock Information
- Founded
- BCAL 2001
- PSNL 2011
- Country
- BCAL United States
- PSNL United States
- Employees
- BCAL N/A
- PSNL N/A
- Industry
- BCAL Major Banks
- PSNL Medical Specialities
- Sector
- BCAL Finance
- PSNL Health Care
- Exchange
- BCAL Nasdaq
- PSNL Nasdaq
- Market Cap
- BCAL 471.0M
- PSNL 426.6M
- IPO Year
- BCAL N/A
- PSNL 2019
- Fundamental
- Price
- BCAL $14.53
- PSNL $6.42
- Analyst Decision
- BCAL Strong Buy
- PSNL Strong Buy
- Analyst Count
- BCAL 1
- PSNL 5
- Target Price
- BCAL $20.00
- PSNL $8.00
- AVG Volume (30 Days)
- BCAL 84.1K
- PSNL 922.2K
- Earning Date
- BCAL 07-28-2025
- PSNL 08-06-2025
- Dividend Yield
- BCAL N/A
- PSNL N/A
- EPS Growth
- BCAL N/A
- PSNL N/A
- EPS
- BCAL 0.62
- PSNL N/A
- Revenue
- BCAL $132,045,000.00
- PSNL $85,694,000.00
- Revenue This Year
- BCAL $74.16
- PSNL $0.45
- Revenue Next Year
- BCAL $4.92
- PSNL $25.75
- P/E Ratio
- BCAL $23.29
- PSNL N/A
- Revenue Growth
- BCAL 42.63
- PSNL 15.57
- 52 Week Low
- BCAL $11.87
- PSNL $1.14
- 52 Week High
- BCAL $18.49
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- BCAL 48.10
- PSNL 72.69
- Support Level
- BCAL $14.07
- PSNL $6.06
- Resistance Level
- BCAL $15.04
- PSNL $6.72
- Average True Range (ATR)
- BCAL 0.40
- PSNL 0.44
- MACD
- BCAL -0.08
- PSNL 0.10
- Stochastic Oscillator
- BCAL 35.66
- PSNL 85.65
About BCAL Southern California Bancorp
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.